These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 17998773

  • 1. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
    Takahashi T, Ono H, Ono Y, Ishimitsu T, Matsuoka H.
    Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y, Ono H, Zhou X, Frohlich ED.
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 May; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 5. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
    Naruse M, Tanabe A, Hara Y, Takagi S, Imaki T, Takano K.
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
    [Abstract] [Full Text] [Related]

  • 6. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S, Nishikimi T, Inaba C, Akimoto K, Matsuoka H.
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [Abstract] [Full Text] [Related]

  • 7. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
    Omote Y, Deguchi K, Kurata T, Yamashita T, Sato K, Hishikawa N, Abe K.
    Curr Neurovasc Res; 2015 Sep; 12(1):91-7. PubMed ID: 25557372
    [Abstract] [Full Text] [Related]

  • 8. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H.
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [Abstract] [Full Text] [Related]

  • 9. Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.
    Attia YM, Elalkamy EF, Hammam OA, Mahmoud SS, El-Khatib AS.
    Parasit Vectors; 2013 Jul 05; 6():199. PubMed ID: 23829789
    [Abstract] [Full Text] [Related]

  • 10. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O, Minamino T, Sanada S, Okada K, Hirata A, Fujita M, Shintani Y, Yulin L, Asano Y, Takashima S, Yamasaki S, Tomoike H, Hori M, Kitakaze M.
    Cardiovasc Drugs Ther; 2006 Apr 05; 20(2):93-102. PubMed ID: 16761190
    [Abstract] [Full Text] [Related]

  • 11. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
    Tsukuda K, Mogi M, Iwanami J, Min LJ, Sakata A, Jing F, Iwai M, Horiuchi M.
    Hypertension; 2009 Oct 05; 54(4):782-7. PubMed ID: 19635982
    [Abstract] [Full Text] [Related]

  • 12. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1996 Feb 05; 27(2):176-83. PubMed ID: 8567038
    [Abstract] [Full Text] [Related]

  • 13. Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells.
    Chen Y, Luo Q, Xiong Z, Liang W, Chen L, Xiong Z.
    Int J Clin Exp Pathol; 2012 Feb 05; 5(6):522-9. PubMed ID: 22949934
    [Abstract] [Full Text] [Related]

  • 14. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    J Hypertens; 2002 May 05; 20(5):993-1000. PubMed ID: 12011661
    [Abstract] [Full Text] [Related]

  • 15. Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma.
    Maejima Y, Okada H, Haraguchi G, Onai Y, Kosuge H, Suzuki J, Isobe M.
    Lab Invest; 2011 Jun 05; 91(6):932-44. PubMed ID: 21403641
    [Abstract] [Full Text] [Related]

  • 16. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T.
    Hypertens Res; 2007 Jan 05; 30(1):63-75. PubMed ID: 17460373
    [Abstract] [Full Text] [Related]

  • 17. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
    Akashiba A, Ono H, Ono Y, Ishimitsu T, Matsuoka H.
    J Cardiol; 2008 Dec 05; 52(3):239-46. PubMed ID: 19027602
    [Abstract] [Full Text] [Related]

  • 18. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ).
    Miana M, de Las Heras N, Rodriguez C, Sanz-Rosa D, Martin-Fernandez B, Mezzano S, Lahera V, Martinez-Gonzalez J, Cachofeiro V.
    J Physiol Pharmacol; 2011 Feb 05; 62(1):87-94. PubMed ID: 21451213
    [Abstract] [Full Text] [Related]

  • 19. Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
    Inada H, Ono H, Minami J, Ishimitsu T, Matsuoka H.
    Hypertens Res; 2002 May 05; 25(3):433-40. PubMed ID: 12135323
    [Abstract] [Full Text] [Related]

  • 20. Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion.
    Deguchi K, Kurata T, Fukui Y, Liu W, Yun Z, Omote Y, Sato K, Kono S, Hishikawa N, Yamashita T, Abe K.
    J Stroke Cerebrovasc Dis; 2014 May 05; 23(10):2646-2653. PubMed ID: 25307428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.